Constitutional symptoms of severe childhood-onset polyarteritis nodosa
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Pavneet Kaur, Srinivasavaradan Govindarajan, Manisha Jana, Aditi […]
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Pavneet Kaur, Srinivasavaradan Govindarajan, Manisha Jana, Aditi […]
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Torsten Diekhoff, Denis Poddubnyy
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Amy C D Peeters, Celia A J
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Maciej Wieczorek, Bartłomiej Kisiel, Dorota Włodarczyk, Piotr
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Dennis A Ton, Nikolet K den Hollander,
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Hazel J Jenkins, Leticia Corrêa, Benjamin T
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Jennifer Thorley
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Yoo Jin Kim, Phebe Ismail, Michelle Petri,
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Rushab C Shah, Laura J Ross, Maya
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Fabiola Atzeni, James Galloway
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Mami Tamai, Atsushi Kawakami
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Jo Nijs, Elin Johansson
Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): The Lancet Rheumatology
At this year’s AIMed25 conference, attendees will learn more about the future of AI in health care from industry leaders,
State legislatures have become the front lines in the battle for affordable medications and improved access to rheumatology care for
Ocul Immunol Inflamm. 2025 Aug 19:1-3. doi: 10.1080/09273948.2025.2548949. Online ahead of print. ABSTRACT PURPOSE: Tubulointerstitial nephritis and uveitis (TINU) syndrome
Rheumatol Int. 2025 Aug 19;45(9):200. doi: 10.1007/s00296-025-05961-w. ABSTRACT To estimate the prevalence of musculoskeletal pain (MSP) across age groups in
Clin Rheumatol. 2025 Aug 19. doi: 10.1007/s10067-025-07660-0. Online ahead of print. NO ABSTRACT PMID:40828361 | DOI:10.1007/s10067-025-07660-0
Adv Ther. 2025 Aug 19. doi: 10.1007/s12325-025-03317-1. Online ahead of print. ABSTRACT INTRODUCTION: The aim of this study was to
Cytotherapy. 2025 Jul 12:S1465-3249(25)00744-3. doi: 10.1016/j.jcyt.2025.06.005. Online ahead of print. ABSTRACT BACKGROUND: Mesenchymal stromal cells (MSCs) have been employed in
Acta Orthop. 2025 Aug 19;96:640-649. doi: 10.2340/17453674.2025.44482. ABSTRACT BACKGROUND AND PURPOSE: The optimal duration of antibiotic prophylaxis for reducing serious
Liver Int. 2025 Sep;45(9):e70293. doi: 10.1111/liv.70293. ABSTRACT Celiac disease (CeD) has been linked to both autoimmunity and chronic liver disease,
Ugeskr Laeger. 2025 Aug 11;187(33):V09240622. doi: 10.61409/V09240622. ABSTRACT Juvenile idiopathic arthritis (JIA) presents ongoing treatment challenges despite advances in treatment
J Bone Miner Res. 2025 Aug 19:zjaf110. doi: 10.1093/jbmr/zjaf110. Online ahead of print. ABSTRACT BACKGROUND: Romosozumab is a monoclonal antibody
J Bone Miner Res. 2025 Aug 19:zjaf113. doi: 10.1093/jbmr/zjaf113. Online ahead of print. ABSTRACT Fracture risk is commonly assessed by
Scand J Rheumatol. 2025 Aug 19:1-3. doi: 10.1080/03009742.2025.2528311. Online ahead of print. NO ABSTRACT PMID:40827399 | DOI:10.1080/03009742.2025.2528311
Stat Med. 2025 Aug;44(18-19):e70189. doi: 10.1002/sim.70189. ABSTRACT In clinical practice, multiple biomarkers are often measured on the same subject for